HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 8,353.884 million compared to CNY 7,055.220 million a year ago. Operating income was CNY 363.729 million compared to CNY 349.865 million a year ago. Net income was CNY 267.334 million compared to CNY 257.859 million a year ago. Basic earnings per share from continuing operations was CNY 0.461 compared to CNY 0.4447 a year ago.